This holding company operates a subsidiary in the form of a clinical stage biopharmaceutical company. This company is focused on the discovery and development of treatments for severe rare conditions.
This holding company operates a subsidiary in the form of a clinical stage biopharmaceutical company. This company is focused on the discovery and development of treatments for severe rare conditions.